EP1210110A4 - Proteines de liaison a la proteine prion, et leurs utilisations - Google Patents
Proteines de liaison a la proteine prion, et leurs utilisationsInfo
- Publication number
- EP1210110A4 EP1210110A4 EP00943291A EP00943291A EP1210110A4 EP 1210110 A4 EP1210110 A4 EP 1210110A4 EP 00943291 A EP00943291 A EP 00943291A EP 00943291 A EP00943291 A EP 00943291A EP 1210110 A4 EP1210110 A4 EP 1210110A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- binding proteins
- protein binding
- prion protein
- prion
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34242699A | 1999-06-29 | 1999-06-29 | |
US342426 | 1999-06-29 | ||
PCT/US2000/017927 WO2001000235A1 (fr) | 1999-06-29 | 2000-06-29 | Proteines de liaison a la proteine prion, et leurs utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1210110A1 EP1210110A1 (fr) | 2002-06-05 |
EP1210110A4 true EP1210110A4 (fr) | 2003-03-19 |
Family
ID=23341775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00943291A Withdrawn EP1210110A4 (fr) | 1999-06-29 | 2000-06-29 | Proteines de liaison a la proteine prion, et leurs utilisations |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1210110A4 (fr) |
JP (1) | JP2003531356A (fr) |
AU (1) | AU5778400A (fr) |
CA (1) | CA2376914A1 (fr) |
WO (1) | WO2001000235A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7041807B1 (en) | 1999-06-23 | 2006-05-09 | Caprion Pharmaceuticals, Inc. | Antibodies to a YYX epitope of a mammalian prion protein |
IL153824A0 (en) * | 2000-07-07 | 2003-07-31 | Applied Research Systems | Method and kit for diagnosis of diseases |
CA2812761C (fr) | 2001-10-05 | 2018-03-20 | Steris Inc. | Modele in vitro d'activite antiprions |
US20040072236A1 (en) * | 2002-09-27 | 2004-04-15 | Neil Cashman | PrPSc -interacting molecules and uses thereof |
EP1573323B1 (fr) * | 2002-12-03 | 2011-10-19 | Pathogen Removal and Diagnostic Technologies, Inc. | Ligands de proteine prion et procedes d'utilisation |
US20050054003A1 (en) * | 2003-09-10 | 2005-03-10 | Stenland Christopher J. | Prion clearance using particulate metal oxides |
EP1571449A1 (fr) * | 2004-03-01 | 2005-09-07 | Stichting Sanquin Bloedvoorziening | Test immunologique pour prions et méthode de séparation |
GB0519198D0 (en) * | 2005-09-20 | 2005-10-26 | Univ Cambridge Tech | Tse detection |
EP2407554A1 (fr) | 2010-07-14 | 2012-01-18 | Fundacio Institut de Recerca de l'Hospital Universitari Vall d'Hebron | Procédés et kits pour le diagnostic du cancer de la prostate |
EP2407555A1 (fr) | 2010-07-14 | 2012-01-18 | Fundació Institut de Recerca Hospital Universitari Vall d'Hebron, Fundació Privada | Procédés et kits pour le diagnostic du cancer de la prostate |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993023432A1 (fr) * | 1992-05-15 | 1993-11-25 | New York University | Polypeptides de pion solubles et procedes de detection et de purification |
EP1186662A2 (fr) * | 1996-05-29 | 2002-03-13 | McGILL UNIVERSITY | Protéines de liaison au prion et leurs utilisations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4806627A (en) * | 1987-05-29 | 1989-02-21 | Research Foundation Of Mental Hygiene Inc. | Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins |
US5679530A (en) * | 1995-04-12 | 1997-10-21 | Ludwig Institute For Cancer Research | Isolated protein having molecular weight of from about 55 kilodaltons to about 65 kilodaltons (SDS-page) which binds to prion protein |
US5750361A (en) * | 1995-11-02 | 1998-05-12 | The Regents Of The University Of California | Formation and use of prion protein (PRP) complexes |
AU3186397A (en) * | 1996-05-29 | 1998-01-05 | Mcgill University | Prion protein binding proteins and uses thereof |
-
2000
- 2000-06-29 WO PCT/US2000/017927 patent/WO2001000235A1/fr not_active Application Discontinuation
- 2000-06-29 AU AU57784/00A patent/AU5778400A/en not_active Abandoned
- 2000-06-29 CA CA002376914A patent/CA2376914A1/fr not_active Abandoned
- 2000-06-29 JP JP2001505942A patent/JP2003531356A/ja active Pending
- 2000-06-29 EP EP00943291A patent/EP1210110A4/fr not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993023432A1 (fr) * | 1992-05-15 | 1993-11-25 | New York University | Polypeptides de pion solubles et procedes de detection et de purification |
EP1186662A2 (fr) * | 1996-05-29 | 2002-03-13 | McGILL UNIVERSITY | Protéines de liaison au prion et leurs utilisations |
Non-Patent Citations (7)
Title |
---|
BROWN DAVID R ET AL: "The cellular prion protein binds copper in vivo.", NATURE (LONDON), vol. 390, no. 6661, 18 December 1997 (1997-12-18), pages 684 - 687, XP002206825, ISSN: 0028-0836 * |
FORLONI G ET AL: "Neurotoxicity of a prion protein fragment.", NATURE. ENGLAND 8 APR 1993, vol. 362, no. 6420, 8 April 1993 (1993-04-08), pages 543 - 546, XP000941706, ISSN: 0028-0836 * |
HOFFMANN INES ET AL: "Cloning and Expression Analysis of a Novel Mesodermally Expressed Cadherin.", DEVELOPMENTAL BIOLOGY, vol. 169, no. 1, 1995, pages 337 - 346, XP000576704, ISSN: 0012-1606 * |
KURSCHNER C ET AL: "ANALYSIS OF INTERACTION SITES IN HOMO- AND HETEROMERIC COMPLEXES CONTAINING BCL-2 FAMILY MEMBERS AND THE CELLULAR PRION PROTEIN", MOLECULAR BRAIN RESEARCH, ELSEVIER SCIENCE BV, AMSTERDAM, NL, vol. 37, no. 1/2, 1996, pages 249 - 258, XP002056075, ISSN: 0169-328X * |
RIEGER R ETAL: "The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells", NATURE MEDICINE, NATURE PUBLISHING, CO, US, vol. 3, no. 12, 1 December 1997 (1997-12-01), pages 1383 - 1388, XP002094757, ISSN: 1078-8956 * |
See also references of WO0100235A1 * |
SUGIMOTO KEISHI ET AL: "Molecular cloning and characterization of a newly identified member of the cadherin family, PB-cadherin.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 271, no. 19, 1996, pages 11548 - 11556, XP002206824, ISSN: 0021-9258 * |
Also Published As
Publication number | Publication date |
---|---|
EP1210110A1 (fr) | 2002-06-05 |
WO2001000235A1 (fr) | 2001-01-04 |
AU5778400A (en) | 2001-01-31 |
JP2003531356A (ja) | 2003-10-21 |
CA2376914A1 (fr) | 2001-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL121860A0 (en) | Interleukin-18 binding proteins their preparation and use | |
AU5091199A (en) | Prion protein and uses thereof | |
GB9921125D0 (en) | Proteins | |
AU7829700A (en) | Protein phosphatase and kinase proteins | |
EP1210110A4 (fr) | Proteines de liaison a la proteine prion, et leurs utilisations | |
EP1186615A4 (fr) | Proteine et adn de cette proteine | |
GB9928950D0 (en) | Binding protein | |
GB9918155D0 (en) | Proteins and peptides | |
EP1189938A4 (fr) | Proteines secretees et utilisations associees | |
AU2136401A (en) | P450rai-2 and related proteins | |
EP1080185A4 (fr) | Peptides de proteine basique de myeline et utilisations de ceux-ci | |
EP1179000A4 (fr) | Proteines secretees et leurs utilisations | |
AU5495500A (en) | Decorin binding protein essential peptides and methods of use | |
AU1320600A (en) | Human rna binding proteins | |
EP1044212A4 (fr) | Proteines de liaisons fk506 humaines | |
EP1142999A4 (fr) | Proteine et adn associe | |
AU2001276899A1 (en) | Mammalian mdm2 binding proteins and uses thereof | |
AU6894398A (en) | Human gtp binding protein | |
EP1159413A4 (fr) | Proteines secretees et utilisations | |
EP1127066A4 (fr) | Proteines modifiees | |
EP1111047A4 (fr) | Nouvelle proteine et son adn | |
AU2001256454A1 (en) | Prion proteins and their uses | |
NZ513920A (en) | Novel proteins and uses thereof | |
GB9726956D0 (en) | Protein binding polypeptides | |
HK1093750A1 (en) | Binding molecules for human factor viii and factor viii-like proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020129 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030131 |
|
17Q | First examination report despatched |
Effective date: 20030512 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MCGILL UNIVERSITY Owner name: CAPRION PHARMACEUTICALS, INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030923 |